Becton, Dickinson and Company (LON: 0R19)
London
· Delayed Price · Currency is GBP · Price in USD
247.89
-1.81 (-0.72%)
Jan 31, 2025, 6:54 PM BST
Becton, Dickinson and Company Revenue
In the fiscal year ending September 30, 2024, Becton, Dickinson and Company had annual revenue of $20.18B USD with 4.16% growth. Becton, Dickinson and Company had revenue of $5.44B in the quarter ending September 30, 2024.
Revenue
$20.18B
Revenue Growth
+4.16%
P/S Ratio
n/a
Revenue / Employee
$272.68K
Employees
74,000
Market Cap
57.77B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 20.18B | 806.00M | 4.16% |
Sep 30, 2023 | 19.37B | 502.00M | 2.66% |
Sep 30, 2022 | 18.87B | -261.00M | -1.36% |
Sep 30, 2021 | 19.13B | 3.06B | 19.02% |
Sep 30, 2020 | 16.07B | -1.22B | -7.03% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
Hikma Pharmaceuticals | 2.39B |
ConvaTec Group | 1.74B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
Becton, Dickinson and Company News
- 4 days ago - Becton, Dickinson and Company to effect additional $10M share repurchase program - Seeking Alpha
- 4 days ago - BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $750 Million Repurchase to Date in FY25 - PRNewsWire
- 9 days ago - What Can The Dividend Kings Deliver In 2025? - Seeking Alpha
- 10 days ago - BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development - PRNewsWire
- 11 days ago - Carilion Clinic First in Virginia to Offer Needle-free In-patient Blood Draws, Redefining Patient Standard of Care - PRNewsWire
- 11 days ago - Masimo Taps Katie Szyman as Permanent CEO - The Wall Street Journal
- 12 days ago - Insider Sell: Michael Garrison Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
- 16 days ago - Price Over Earnings Overview: Becton Dickinson - Benzinga